Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.

Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.

Veitonmäki T, Tammela TL, Auvinen A, Murtola TJ.

Eur J Cancer. 2013 Mar;49(4):938-45. doi: 10.1016/j.ejca.2012.09.030. Epub 2012 Oct 15.

PMID:
23079475
2.

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.

Jacobs EJ, Rodriguez C, Mondul AM, Connell CJ, Henley SJ, Calle EE, Thun MJ.

J Natl Cancer Inst. 2005 Jul 6;97(13):975-80.

PMID:
15998950
3.

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.

Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):390-6.

4.

Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.

Schmidt M, Christiansen CF, Mehnert F, Rothman KJ, Sørensen HT.

BMJ. 2011 Jul 4;343:d3450. doi: 10.1136/bmj.d3450.

5.

Aspirin and the risk of prostate cancer.

Bosetti C, Talamini R, Negri E, Franceschi S, Montella M, La Vecchia C.

Eur J Cancer Prev. 2006 Feb;15(1):43-5.

PMID:
16374228
6.

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.

Murtola TJ, Tammela TL, Lahtela J, Auvinen A.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2226-32.

7.

Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.

Veitonmäki T, Murtola TJ, Määttänen L, Taari K, Stenman UH, Tammela TL, Auvinen A.

Prostate. 2015 Sep;75(13):1394-402. doi: 10.1002/pros.23020. Epub 2015 Jun 12.

PMID:
26073992
8.

Underutilization of preventive strategies in patients receiving NSAIDs.

Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.

Rheumatology (Oxford). 2003 Nov;42 Suppl 3:iii23-31.

PMID:
14585915
9.

A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs, and Hodgkin lymphoma risk in Denmark.

Chang ET, Frøslev T, Sørensen HT, Pedersen L.

Br J Cancer. 2011 Nov 22;105(11):1776-82. doi: 10.1038/bjc.2011.443. Epub 2011 Oct 25.

10.

Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study.

Johannesdottir SA, Chang ET, Mehnert F, Schmidt M, Olesen AB, Sørensen HT.

Cancer. 2012 Oct 1;118(19):4768-76. doi: 10.1002/cncr.27406. Epub 2012 May 29.

11.

Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.

Mahmud SM, Tanguay S, Bégin LR, Franco EL, Aprikian AG.

Eur J Cancer Prev. 2006 Apr;15(2):158-64.

PMID:
16523013
12.

"Selective" switching from non-selective to selective non-steroidal anti-inflammatory drugs.

Bennett K, Teeling M, Feely J.

Eur J Clin Pharmacol. 2003 Nov;59(8-9):645-9. Epub 2003 Aug 27.

PMID:
12942226
13.

Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.

Veitonmäki T, Murtola TJ, Talala K, Taari K, Tammela T, Auvinen A.

PLoS One. 2016 Apr 21;11(4):e0153413. doi: 10.1371/journal.pone.0153413. eCollection 2016.

14.

Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.

Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M.

BMC Cancer. 2005 Dec 12;5:159.

15.

The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case-control study.

Kemppainen KJ, Tammela TL, Auvinen A, Murtola TJ.

Cancer Causes Control. 2011 Oct;22(10):1445-52. doi: 10.1007/s10552-011-9819-3. Epub 2011 Jul 19.

PMID:
21769492
16.
17.

Use of low-dose aspirin and non-aspirin nonsteroidal anti-inflammatory drugs and risk of glioma: a case-control study.

Gaist D, García-Rodríguez LA, Sørensen HT, Hallas J, Friis S.

Br J Cancer. 2013 Mar 19;108(5):1189-94. doi: 10.1038/bjc.2013.87. Epub 2013 Feb 28.

18.

Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study.

Cronin-Fenton DP, Pedersen L, Lash TL, Friis S, Baron JA, Sørensen HT.

Breast Cancer Res. 2010;12(2):R15. doi: 10.1186/bcr2482. Epub 2010 Mar 1.

19.

Regular use of aspirin and prostate cancer risk (United States).

Menezes RJ, Swede H, Niles R, Moysich KB.

Cancer Causes Control. 2006 Apr;17(3):251-6.

PMID:
16489532
20.

Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence.

Dasgupta K, Di Cesar D, Ghosn J, Rajan R, Mahmud S, Rahme E.

Cancer J. 2006 Mar-Apr;12(2):130-5.

PMID:
16630404

Supplemental Content

Support Center